Occlusion Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Occlusion Devices market is Segmented by Product (Occlusion Removal Devices, Embolization Devices, and Support Devices), Application, End-User, and Geography

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors for the growth of the occlusion devices market include the rising adoption of minimally invasive surgeries, increasing geriatric population, and rising prevalence of chronic diseases such as cancer along with technological advancements.

The rising adoption of minimally invasive surgeries is expected to drive the overall growth of the market. Minimally invasive surgeries (MIS) cause less post-operative pain. The occlusion devices are used with minimal cuts or stitches involved, the hospital stay is relatively shorter and this technology is proving its efficiency in treatment while performing complex surgeries. Furthermore, there is a rising geriatric population leading to the high prevalence of chronic diseases such as cancer, and cardiovascular diseases. According to the WHO, by 2050, the world’s population aged 60 years and older is expected to reach a total of 2 billion. Thus, rising geriatric population and an increase in the adoption of minimally invasive surgeries the market is expected to boost the growth of the occlusion devices market.

Scope of the Report

As per the scope of this report, occlusion devices are used to create occlusion in the vessels in order to stop the blood flow or remove the occlusion. The Occlusion Devices market is segmented by product, application, end-user, and geography.

By Product
Occlusion Removal Devices
Coil Retrievers
Stent Retrievers
Others
Embolization Devices
Support Devices
By Application
Peripheral Vascular Disease
Neurology
Oncology
Urology
Others
By End User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Neurology Segment by Application is Expected to Witness a Lucrative Growth

Artery occlusion and bypass is a two-part procedure combining open microsurgery and endovascular coiling. The purpose of this procedure is to coil the entire diseased portion of the blood vessel and then bypass the blood flow to the specific location in the brain. The difference between this procedure and endovascular coiling is that this procedure closes down (occludes) the whole vessel rather than just putting coils in the aneurysm sac.

The rising prevalence of brain aneurysm and the launch of new technologically advanced products are expected to drive the overall growth of the market. According to 2020 estimates of the Brain Aneurysm Foundation, 6.5 million people in the United States have an unruptured brain aneurysm. Furthermore, approximately 30,000 people in the United States suffer a brain aneurysm rupture each year. 

Women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men. This risk is expected to increase in the future as the geriatric population is increasing. As per a 2017 United Nations, the global population aged 60 years or above is expected to increase from 12.7% in 2017 to 21.3% by 2050. This is expected to increase the incidence of aneurysm. Hence, increasing incidence is expected to help the market growth.

graph.png

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest occlusion devices market owing to the rising adoption of minimally invasive surgeries and the presence of better healthcare infrastructure. Furthermore, rising approval of new occlusion devices is expected to boost the overall growth of the market. 

Recently, one of the market player Abbott Laboratories received approval from FDA for the Amplatzer Piccolo Occluder, which is the world's first medical device that can be implanted in babies using a minimally invasive procedure to treat patent ductus arteriosus. The advantages of minimally invasive surgeries, such as less invasiveness, the quick recovery time of patients, and the low cost of treatment, have augmented the growth of the market in the region. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

GEO.png

Competitive Landscape

The market studied is a consolidated market owing to the presence of few major market players. Some of the market players are Abbott Laboratories, Boston Scientific Corporation, BTG International Ltd, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Merit Medical Systems, Penumbra, Inc., Stryker Corporation, and Terumo Corporation.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Adoption of Minimally Invasive Surgeries

      2. 4.2.2 Increasing Geriatric Population and Rising Burden of Chronic Diseases

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Products

      2. 4.3.2 Requirement of Skilled Professionals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Occlusion Removal Devices

        1. 5.1.1.1 Coil Retrievers

        2. 5.1.1.2 Stent Retrievers

        3. 5.1.1.3 Others

      2. 5.1.2 Embolization Devices

      3. 5.1.3 Support Devices

    2. 5.2 By Application

      1. 5.2.1 Peripheral Vascular Disease

      2. 5.2.2 Neurology

      3. 5.2.3 Oncology

      4. 5.2.4 Urology

      5. 5.2.5 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 BTG International Ltd

      4. 6.1.4 Edwards Lifesciences Corporation

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Medtronic plc

      7. 6.1.7 Merit Medical Systems

      8. 6.1.8 Penumbra, Inc.

      9. 6.1.9 Stryker Corporation

      10. 6.1.10 Terumo Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Occlusion Devices Market market is studied from 2018 - 2026.

The Occlusion Devices Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, Boston Scientific Corporation, BTG International Ltd, Edwards Lifesciences Corporation, Medtronic plc are the major companies operating in Occlusion Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!